BG. MK5 haplodeficiency attenuates hypertrophy and preserves diastolic function during remodeling induced by chronic pressure overload in the mouse heart. activated protein kinase-5 (MK5) is a protein serine/threonine kinase that is activated by p38 MAPK and the atypical MAPKs ERK3 and ERK4. The physiological function(s) of MK5 remains unknown. Here, we examined the effect of MK5 haplodeficiency on cardiac function and myocardial remodeling. At 12 wk of age, MK5 haplodeficient mice (MK5 ϩ/Ϫ ) were smaller than age-matched wild-type littermates (MK5 ϩ/ϩ ), with similar diastolic function but reduced systolic function. Transverse aortic constriction (TAC) was used to induce chronic pressure overload in 12-wk-old male MK5 ϩ/Ϫ and MK5 ϩ/ϩ mice. Two weeks post-TAC, heart weight-to-tibia length ratios were similarly increased in MK5 ϩ/Ϫ and MK5 ϩ/ϩ hearts, as was the abundance of B-type natriuretic peptide and ␤-myosin heavy chain mRNA. Left ventricular ejection fraction was reduced in both MK5 ϩ/ϩ and MK5 ϩ/Ϫ mice, whereas regional peak systolic tissue velocities were reduced and isovolumetric relaxation time was prolonged in MK5 ϩ/ϩ hearts but not in MK5 ϩ/Ϫ hearts. The TAC-induced increase in collagen type 1-␣ 1 mRNA observed in MK5 ϩ/ϩ hearts was markedly attenuated in MK5 ϩ/Ϫ hearts. Eight weeks post-TAC, systolic function was equally impaired in MK5 ϩ/ϩ and MK5 ϩ/Ϫ mice. In contrast, the increase in E wave deceleration rate and progression of hypertrophy observed in TAC MK5 ϩ/ϩ mice were attenuated in TAC MK5 ϩ/Ϫ mice. MK5 immunoreactivity was detected in adult fibroblasts but not in myocytes. MK5 ϩ/ϩ , MK5 ϩ/Ϫ , and MK5 Ϫ/Ϫ fibroblasts all expressed ␣-smooth muscle actin in culture. Hence, reduced MK5 expression in cardiac fibroblasts was associated with the attenuation of both hypertrophy and development of a restrictive filling pattern during myocardial remodeling in response to chronic pressure overload.
WHEN FACED with a chronic hemodynamic overload, such as imposed by arterial hypertension or myocardial infarction, the heart undergoes a series of adaptive responses that includes molecular remodeling, hypertrophy, fibroblast recruitment and proliferation, interstitial fibrosis, and extracellular matrix remodeling. The purposes of these changes are to 1) generate additional sarcomeres so that the heart can generate additional force to compensate for the increased load, 2) structurally reinforce the myocardium, and 3) distribute contractile force throughout the myocardium. Cardiac hypertrophy, the increase in ventricular mass resulting from an increase in cardiomyocyte size, is the heart's adaptive response to an increase in hemodynamic load arising from either physiological factors such as exercise or pathological stress and represents the heart's attempt to maintain cardiac output. Exercise-induced, or physiological, hypertrophy is not associated with interstitial fibrosis and does not progress to heart failure. Chronic pressure overload, on the other hand, induces a compensatory hypertrophy that, if left unchecked, can progress to a decompensated hypertrophy, resulting in contractile dysfunction, arrhythmias, and ultimately heart failure. In contrast to physiological hypertrophy, pressure overload also induces interstitial fibrosis, which, in turn, increases both the occurrence of ventricular tachyarrhythmias and the stiffness of myocardium, resulting in diastolic dysfunction (2, 20, 24) .
Chronic pressure overload activates MAPKs, including p38 (13) . Chronic activation of p38 induces interstitial fibrosis but not hypertrophy (60) . In contrast, acute activation of p38 results in the rapid induction of a severe cardiomyopathy that includes myocyte hypertrophy, interstitial fibrosis, and contractile dysfunction (51) . There are four known isoforms of p38 (␣, ␤, ␦, and ␥), with p38␣ and p38␥ being the most abundant in the heart (9, 12) . Downstream of p38␣ and p38␤ lie the MAPK-activated protein kinases (MKs): MK2, MK3, and MK5 (41) . MK5, originally classified as a p38-regulated/ activated protein kinase (PRAK) (32, 33) , has been implicated in senescence upon activation of p38 by oncogenic Ras (52) . In addition to p38, MK5 is phosphorylated by the atypical MAPKs ERK3 and ERK4 (21, 46, 49) . However, the physio-logical role of MK5, as well as its role in p38 and ERK3/4 signaling in vivo, remains unknown. Here, we used heterozygous mice that bear a null allele of MK5 (MK5 ϩ/Ϫ ) (50) to study the role of MK5 signaling in pressure overload-induced myocardial remodeling. Compared with wild-type littermates, the development of progressive hypertrophy was significantly attenuated in MK5 ϩ/Ϫ mice. The increase in collagen type 1-␣ 1 (COL1A1) mRNA levels induced by pressure overload was also reduced in MK5 ϩ/Ϫ mice. Whereas reduced MK5 expression preserved diastolic function, systolic function was similarly impaired in both MK5 ϩ/ϩ and MK5 ϩ/Ϫ mice during pressure overload. Interestingly, MK5 immunoreactivity was detected in fibroblasts but not in myocytes, suggesting that MK5 plays a role the response of cardiac fibroblasts to chronic pressure overload and the subsequent pathological remodeling.
MATERIAL AND METHODS
Materials. SDS-PAGE reagents, nitrocellulose, and Bradford protein assay reagents were from Bio-Rad Laboratories. Membrane grade Triton X-100, leupeptin, and PMSF were from Roche Molecular Biochemicals. Rabbit anti-collagen type I (no. 203002) was from MD Biosciences. Mouse anti-GAPDH (no. 4300) was from Ambion. Rabbit anti-MK-5 (no. D70A10) was from Cell Signaling Technology. Goat anti-caveolin-3 (no. SC7665) was from Santa Cruz Biotechnology. Rabbit anti-MK-5 phospho-Thr 182 (no. ab138668) and mouse anti-cardiac troponin T (no. ab8295) were from Abcam Biotechnology Co. Horseradish peroxidase-conjugated secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA). All other reagents were of analytic grade or the best grade available. Primers for quantitative PCR were from Invitrogen. Lysates of human embryonic kidney-293 cells expressing MK5.1-V5 were prepared as previously described (11) .
Knockout mice. The MK5 knockout mice used in these experiments have been previously described (50) and were on a mixed 129/Ola ϫ C57BL background. Twelve-to thirteen-week-old male MK5 ϩ/ϩ and MK5 ϩ/Ϫ littermates were used in these experiments (n ϭ 18 -26). MK5 Ϫ/Ϫ mice show embryonic lethality with incomplete penetrance resulting in only~50% of the expected number of MK5 Ϫ/Ϫ embryos detectable after embryonic day 12 (E12). Surviving MK5 Ϫ/Ϫ mice fail to reproduce. MK5 ϩ/Ϫ mice are healthy. All animal experiments were approved by the local ethics committee and performed according to guidelines of the Canadian Council on Animal Care.
Transverse aortic constriction. Baseline assessments of cardiac structure and function were performed by transthoracic echocardiography (see below). The following day, transverse aortic constriction (TAC) was done as previously described (38) in adult (12-13 wk) male mice anesthetized with isofluorane gas plus buprenorphine (0.05 mg/kg, intraperitoneal injection). A 7-0 silk suture was used to constrict the transverse aorta, between the left and right carotid arteries, around a 27-gauge piece of stainless steel tubing. The suture was knotted, and the steel tube was removed. The result was a constriction of the transverse aorta of~60%. Sham-operated (sham) animals underwent the identical surgical procedure but the aorta was not constricted. The surgeon was blinded to the genotype of the mice. Two and eight weeks after surgery, assessment by transthoracic echocardiography was repeated. The next day, mice were anesthetized with pentobarbital, and in vivo cardiac function was assessed using a Millar Mikro-Tip pressure catheter via the right carotid artery. Mice were then euthanized, and the hearts were removed, weighed, snap frozen in liquid nitrogen-chilled 2-methyl butane, and stored at Ϫ80°C. Pentobarbital, rather than isoflurane, was always used before sacrifice as isofluorane activates p38 in the mouse heart (data not shown).
Transthoracic echocardiography and calculations. Transthoracic echocardiography was performed on mice that had been mildly sedated with isofluorane 1 day before TAC and 1 day before death using a Vivid 7 Dimension ultrasound system (GE Healthcare Ultrasound, Horten, Norway) and i13L probe (10) (11) (12) (13) (14) . The aortic arch was visualized in a modified parasternal long-axis view to assess flow at the site of constriction: peak velocity and peak and mean gradient were measured using sample volume enlarged pulsed-wave Doppler. The left ventricular (LV) M-mode spectrum was obtained in the parasternal short-axis view at the level of papillary muscles. LV dimensions at both end cardiac diastole (LVDd) and end cardiac systole (LVDs) were measured; the thickness of the LV anterior wall (LVAW) and that of the LV posterior wall (LVPW) at end cardiac diastole were also measured in this view. LV mass was calculated as follows: (LVDd ϩ LVAW ϩ LVPW) 3 Ϫ (LVDd) 3 ϫ 1.055 (29) indexed to body weight (BW). LV fractional shortening (FS) was calculated as follows: (LVDd -LVDs)/LVDd ϫ 100%. To determine LV regional contractility, LV basal lateral and septal peak systolic velocities (S m) were derived by tissue Doppler imaging (TDI). To study LV diastolic properties, pulsed-wave Doppler was used to evaluate transmitral flow in the apical four-chamber view, and peak velocities during early filling (E) and atrial filling (A) were measured. Mitral annulus movement was recorded by TDI; velocities during early filling (E m) and late filling (Am) were measured for both lateral and septal annulus, and lateral and septal E/E m values were calculated. LV isovolumetric relaxation time (IVRT) was measured using sample volume enlarged pulsed-wave Doppler at the conjunction of LV inflow and outflow in the apical five-chamber view and was corrected (IVRTc) by the square root of the R-R interval [IVRT/(RR)1/2] on simultaneously recorded ECG. The time intervals from the end of Am to the beginning of Em (b) and from the beginning to the end of Sm (a) were measured in both lateral and septal TDI, and the LV regional myocardial performance index (MPI) was calculated as (b Ϫ a)/a ϫ 100% for both basal lateral and basal septal walls. The average of three consecutive cardiac cycles was used for each measurement. Special care was taken to obtain similar imaging planes during preoperative and predeath assessments for each animal. The echocardiographer was blinded to the genotype of the mice.
Histological analysis. Staining and collagen quantification were performed in the histology facility in the laboratory of Dr. Martin Sirois at the Montreal Heart Institute by personnel blinded to the treatment group of the sample. Hearts were embedded in Tissue-Tek OCT compound (Sakura Finetek USA), and transverse cryosections (8 m) of the ventricles were prepared and stained with Masson's trichrome. Images were taken at ϫ40 using an Olympus BX46 microscope. Collagen content was quantified using Image Pro Plus version 7 (Media Cybernetics) and expressed as a percentage of the surface area. Perivascular collagen was excluded from the measurements. Myocyte diameter was also determined in trichrome-stained cryosections using Image Pro Plus.
RNA analysis. Total cellular RNA was isolated from transverse cryosections (14 m) of the murine ventricular myocardium using RNeasy Micro kits (2-wk TAC, Qiagen) or whole murine ventricles using RNeasy Mini Kits (8-wk TAC, Qiagen) with minor modifications. For samples from the 2-wk TAC group, total RNA was extracted by vortexing 14-m tissue sections in 300 l TRIzol reagent (Sigma) for 30 s. After samples had been incubated at ambient temperature for 5 min, 60 l chloroform was added, and samples were again vortexed and maintained at ambient temperature for an additional 2-3 min. After centrifugation for 15 min at 18,300 g and 4°C, the upper aqueous phase was collected and diluted with an equal volume of 70% ethanol, and total RNA was purified on Qiagen columns according to the manufacturer's instructions. Finally, total RNA was eluted with 14 l of distilled RNase-free water. cDNA synthesis was performed with 11 l of the isolated total RNA in 20-l reaction volumes as previously described (11) .
Hearts from the 8-wk TAC group were pulverized under liquid nitrogen with a mortar and pestle. Heart powder (20 -25 mg) was weighed out and homogenized at room temperature in 300 l RLT buffer containing 1% (vol/vol) 2-mercaptoethanol using a 2-ml Potter-Elvehjem homogenizer. The homogenate was supplemented with 590 l RNase-free water and 10 l proteinase K, vortexed, incubated at 55°C for 10 min, and then centrifuged for 3 min at 4,000 rpm and 20°C. The supernatant (Ϸ900 l) was transferred to a 1.5-ml tube, and RNA was precipitated by adding 0.5 volumes of 100% ethanol and purified using RNeasy Mini Kits (Qiagen) according to the manufacturer's instructions. RNA was quantified using a NanoDrop ND-1000 spectrophotometer, and only samples having an absorbance at 260 nm-to-280-nm ratio greater than 1.8 were used. cDNA synthesis was performed in a 20-l reaction volume containing 1 g of total RNA as previously described (11) .
Real-time quantitative PCRs were performed as previously described (11) . The primers used are shown in Table 1 . The amplification efficiency for each primer pair was between 90 and 110%, and the threshold cycles values for all the genes examined in the present study were in the range of 18 -25. All samples were normalized to GAPDH, which was amplified in parallel.
Preparation of murine cardiac lysates. Mice were euthanized. Hearts were rapidly removed, snap frozen, and pulverized under liquid nitrogen. Powdered tissue was resuspended using a 2-ml Potter-Elvehjem tissue grinder (25-30 passes) in 1.2 ml of ice-cold lysis buffer composed of 50 mM Tris (pH 7.5 at 4°C), 20 mM ␤-glycerophosphate, 20 mM NaF, 5 mM EDTA, 10 mM EGTA, 1.0% Triton X-100, 1 mM Na 3VO4, 1 M microcystin LR, 5 mM DTT, 10 g/ml leupeptin, 0.5 mM PMSF, and 10 mM benzamidine. Homogenates were then cleared of cellular debris by centrifugation for 30 min at 100,000 g (48,000 rpm) and 4°C in a Beckman TLA-100.3 rotor. Finally, supernatants were collected, aliquoted, snap frozen with liquid nitrogen, and stored at Ϫ80°C. Protein concentrations were determined by a micro Bradford assay as previously described (11) .
Isolation of cardiac ventricular myocytes. Cardiac ventricular myocytes were isolated from 12-to 14-wk-old MK5 ϩ/ϩ mice (36) and used immediately. Briefly, mice were anesthetized with intraperitoneal injection of a combination of pentobarbital sodium (0.55 mg/kg BW) and heparin (1.0 U/kg BW). Hearts were exposed via sternotomy, rapidly excised, and immersed in ice-cold Tyrode solution containing 140 mM NaCl, 5.5 mM KCl, 1 mM MgCl 2, 0.3 mM KH2PO4, 10 mM dextrose, 5 mM HEPES, and 2 mM CaCl2 adjusted to pH 7.5 at room temperature with NaOH. Hearts were mounted on an isolated heart perfusion system (Harvard Apparatus) via cannula-tion of the ascending aorta, and the coronary arteries were perfused at 6 ml/min with modified Tyrode solution (140 mM NaCl, 5.5 mM KCl, 1 mM MgCl2, 0.3 mM NaH2PO4, 5 mM HEPES, and 10 mM dextrose adjusted to pH 7.5 at room temperature with NaOH) containing 200 M CaCl2. After 3 min of perfusion, the buffer was changed to Ca 2ϩ -free Tyrode solution, and perfusion continued for an additional 5 min. Hearts were then enzymatically digested by recirculation with Ca 2ϩ -free Tyrode solution containing 0.5 mg/ml collagenase type II for~25 min. When the myocardial tissue had softened, the LV was dissected away from the remainder of the heart and minced into small pieces in Kruftbrühe medium (20 mM KCl, 10 mM KH2PO4, 10 mM dextrose, 40 mM mannitol, 70 mM L-glutamic acid, 10 mM ␤-hydroxybutyric acid, 20 mM taurine, 10 mM EGTA, and 0.1% albumin adjusted to pH 7.5 at room temperature with NaOH). To promote cell dissociation, the solution and tissue fragments were gently triturated using a transfer pipette, and the suspension was filtered through a 200-m nylon mesh. Cardiomyocytes were separated from noncardiomyocyte cells by centrifugation three times for 3 min each at 200 g. The supernatants from these washing steps were discarded, and the final pellet, containing LV myocytes, was used for subsequent experiments. All solutions were constantly aerated with carbogen gas (95% O2-5% CO2), and solutions and cells were maintained at 37°C throughout the isolation process.
Isolation of cardiac ventricular fibroblasts. Cardiac ventricular fibroblasts were isolated from 12-to 14-wk-old MK5 ϩ/ϩ , MK5 ϩ/Ϫ , and MK5 Ϫ/Ϫ mice as previously described (23) . Briefly, mice were anesthetized with an intraperitoneal injection of pentobarbital sodium (0.55 mg/kg BW). Hearts were excised and placed in sterile PBS containing 137 mM NaCl, 2.7 mM KCl, 4.2 mM Na2HPO4·H2O, and 1.8 mM KH 2PO4 (pH 7.4) at 37°C. Once the atria were removed, the ventricular tissue was minced into small bits and subjected to a series of digestions in dissociation medium (116.4 mM NaCl, 23.4 mM HEPES, 0.94 mM NaH2PO4·H2O, 5.4 mM KCl, 5.5 mM dextrose, 0.4 mM MgSO 4, 1 mM CaCl2, 1 mg/ml BSA, 0.5 mg/ml collagenase type IA, 1 mg/ml trypsin, and 0.020 mg/ml pancreatin, pH 7.4). The digestion was aided by gentle agitation of the tissue on an orbital shaker maintained at 37°C. The digest was centrifuged at 405 g for 5 min, and the resulting pellet suspend in 4 ml of medium 199 supplemented with 10% FBS and 2% penicillin-streptomycin, seeded into two 35-mm cell culture dishes, and incubated in a humidified incubator maintained at 37°C under 5% CO2. The medium was changed after 150 min to remove unattached cells and debris. Cultures from passage 2 were used for the experiments described here.
Immunoblot analysis. Heart, cardiomyocyte, and cardiac fibroblast lysates were separated by SDS-PAGE, and proteins were electrophoretically transferred to nitrocellulose membranes for 90 min at 50 V in CAPS buffer (10 mM CAPS-NaOH and 10% methanol, pH 11). Membranes were blocked for 2 h at room temperature in Tris-buffered saline (25 mM Tris·HCl and 150 mM NaCl (pH 7.5) at room temperature) containing 1% (vol/vol) Tween 20 (TBST) and 5% (wt/vol) nonfat dried milk (Carnation) and then incubated overnight at 5°C with the indicated antibodies diluted 1:1,000 in TBST containing 1% (wt/vol) BSA. Filters were then washed three times in TBST and incubated with the appropriate horseradish peroxidase-conjugated secondary antibody (Jackson ImmunoResearch Laboratories) diluted 1:10,000 in TBST containing 5% (wt/vol) nonfat dried milk. Immunoreactive bands were visualized with Western Lightning Plus ECL reagent (PerkinElmer BioSignal, Montreal, QC, Canada) and Kodak BioMax Light film.
Statistical analysis. The data shown are means Ϯ SE. Two-way ANOVA followed by Bonferroni's multiple-comparison test was performed for statistical comparisons involving two variables (e.g., genotype and TAC) using GraphPad Prism version 6.0h for the Mac OSX (GraphPad Software, La Jolla, CA). For comparisons between two groups, two-tailed t-tests were used. P values of Ͻ0.05 were considered as significant. 
ANP, atrial natriuretic peptide; BNP, B-type natriuretic peptides; ␤-MHC, ␤-myosin heavy chain; TGF, transforming growth factor; COL1A1, collagen type 1-␣1.
RESULTS
The objective of the present study was to determine the effect(s) of reduced MK5 expression on cardiac function and pathological cardiac remodeling induced by a chronic pressure overload using a genetic model of MK5 haploinsufficient mice (50) . Figure 1 shows that MK5 immunoreactivity was reduced in hearts from MK5 ϩ/Ϫ and MK5 Ϫ/Ϫ mice compared with hearts from wild-type littermates. We have previously identified mRNA for four splice variants of MK5 (MK5.2-MK5.5) in the murine ventricular myocardium predicted to translate to proteins of lower molecular mass than MK5.1 (11) . Here, immunoblot analysis revealed both a band at 48 kDa, similar to the predicted molecular mass of MK5, and another at 62 kDa (Fig. 1A) . The 48-kDa band migrated on 10% acrylamide gels with an electrophoretic mobility similar to that of an MK5.1-V5 fusion protein ( Fig. 1B) (11) . Both 48-and 62-kDa bands were reduced by~50% in MK5 ϩ/Ϫ hearts and much more so in hearts from MK5 Ϫ/Ϫ mice ( Fig. 1A ). It should be noted here that the MK5-deficient mice were created by deleting exon 6 within the catalytic domain but contain an intact promoter region. The observed reduced immunoreactivity is presumably a consequence of reduced stability. Examination of 12-wk-old male mice revealed that MK5 ϩ/Ϫ mice were smaller than MK5 ϩ/ϩ mice (MK5 ϩ/ϩ : 25.9 Ϯ 0.5 g, n ϭ 45, and Table 2 ). Hence, at 12 wk of age, MK5 haploinsufficient mice show a modest reduction in systolic function.
Hypertrophic responses in MK5 ϩ/Ϫ mice after TAC. To determine the effects of reduced MK5 expression on cardiac remodeling, 12-wk-old male MK5 ϩ/Ϫ and MK5 ϩ/ϩ littermate mice underwent TAC and were euthanized 2 or 8 wk postsurgery. Direct hemodynamic assessment using a Millar Mikro-Tip pressure catheter showed TAC-induced increases in peak systolic arterial pressure and peak LV pressure that did not differ significantly between TAC MK5 ϩ/ϩ and TAC MK5 ϩ/Ϫ groups ( Table 3 and Fig. 2A) , with an average overall increase in peak systolic arterial pressure of 45 mmHg. In addition, echocardiographic imaging of the aortic arch revealed comparable flow velocities at the site of constriction in TAC MK5 ϩ/ϩ and TAC MK5 ϩ/Ϫ groups ( Table 4 ). Two weeks post-TAC, heart weight-to-tibia length ratios (HW/TL) were increased by 20% in MK5 ϩ/ϩ (from 73.7 Ϯ 3.4 to 88.0 Ϯ 5.4 mg/cm) and by 26% in MK5 ϩ/Ϫ mice (from 70.5 Ϯ 3.8 to 89.0 Ϯ 5.1 mg/cm; Fig. 2B ). The increased HW/TL in MK5 ϩ/ϩ and MK5 ϩ/Ϫ mice indicated the development of similar levels of hypertrophy in both groups. LV mass, determined from echo- Fig. 2C ). The reduced hypertrophy in MK5 haplodeficient mice was also observed at the cellular level upon assessment of myocyte diameter in hearts 8 wk post-TAC ( Fig. 2D ). Furthermore, a plot of LV mass (from echocardiography; Table 4 ) versus LV pressure (from Millar; Table 3 ), yielding a slope of 0.46 Ϯ 0.15 mg/mmHg (n ϭ 10, r 2 ϭ 0.54) for TAC MK5 ϩ/ϩ hearts and Ϫ0.15 Ϯ 0.07 mg/mmHg (n ϭ 11, r 2 ϭ 0.38) for TAC MK5 ϩ/Ϫ hearts (not shown) 8 wk post-TAC, indicated that the manner in which MK5 ϩ/Ϫ mice responded to a chronic increase in pressure was distinctly different from that of their wild-type littermates. Hence, although MK5 haploinsufficient mice initially developed LV hypertrophy to an extent similar to wild-type mice in response to chronic pressure overload, the progression of hypertrophy was attenuated in MK5 ϩ/Ϫ hearts. Fetal gene expression in MK5 ϩ/Ϫ mice after TAC. Pathological LV hypertrophy is associated with molecular remodeling that includes the reexpression of the cardiac fetal genes atrial and B-type natriuretic peptides (ANP and BNP) and ␤-myosin heavy chain (␤-MHC) (3). Hence, ANP, BNP, and ␤-MHC mRNA levels were quantified by quantitative PCR 2 and 8 wk post-TAC. Chronic pressure overload increased ␤-MHC, ANP, and BNP mRNA levels in MK5 ϩ/ϩ hearts; however, the increase in ANP mRNA in MK5 ϩ/Ϫ hearts failed to reach significance (Fig. 3) . Two weeks post-TAC, ANP RNA levels in TAC MK5 ϩ/Ϫ hearts were significantly lower than those in TAC MK5 ϩ/ϩ hearts (P Ͻ 0.05; Fig. 3A ). TAC increased ␤-MHC mRNA in both MK5 ϩ/Ϫ and MK5 ϩ/ϩ hearts 2 wk post-TAC; however, ␤-MHC mRNA levels had returned to near sham levels by 8 wk post-TAC in MK5 ϩ/Ϫ hearts, whereas they remained elevated in MK5 ϩ/ϩ hearts (Fig. 3C) . Eight weeks post-TAC, ␤-MHC RNA levels in TAC MK5 ϩ/Ϫ hearts were significantly lower than those in TAC MK5 ϩ/ϩ hearts (P Ͻ 0.01). There were no significant differences in ANP, BNP, and ␤-MHC mRNA levels between sham MK5 ϩ/Ϫ and sham MK5 ϩ/ϩ hearts. Thus, although MK5 haploinsufficiency did not prevent molecular remodeling in response to pressure overload, the profile of fetal gene reexpression was altered.
Echocardiographic characterization of MK5 ϩ/Ϫ mice after TAC. Ventricular structure and function was assessed by echocardiography. LVDd was reduced in 12-wk-old MK5 ϩ/Ϫ mice ( Table 2) ; although these differences did not reach significance in 2-wk TAC groups, in the 8-wk TAC groups LVDd was significantly reduced in MK5 ϩ/Ϫ mice compared with MK5 ϩ/ϩ mice in both sham and TAC groups ( Table 4 ). In contrast, LVSd, which did not differ significantly between MK5 ϩ/Ϫ mice and MK5 ϩ/ϩ littermates at 12 wk of age (Table  2) , increased in response to pressure overload (Table 4) ; however, the increase in LVDs was significantly less in TAC MK5 ϩ/Ϫ mice than in TAC MK5 ϩ/Ϫ mice 8 wk post-TAC (3.29 Ϯ 0.12 vs. 3.67 Ϯ 0.23 mm, P Ͻ 0.05). As mentioned above, at 12 wk of age, MK5 haplodeficient mice displayed a modest reduction in systolic function ( (Table 4 and Fig. 4A ). TDI was used to determine S m and E m of the basal segments of the interventricular septum and lateral LV wall. After 2 wk of pressure overload, lateral and septal S m were significantly reduced in MK5 ϩ/ϩ but not MK5 ϩ/Ϫ hearts (Table 4 ). Furthermore, IVRTs (Fig. 4B) were prolonged in TAC MK5 ϩ/ϩ but not TAC MK5 ϩ/Ϫ hearts. As observed in 12-wk-old mice ( Table 2) , at 2 wk post-TAC the MPI for MK5 ϩ/Ϫ mice was higher than that for MK5 ϩ/ϩ mice ( Fig. 4D and Table 4 ). Hence, hearts from MK5 ϩ/Ϫ mice maintained diastolic function during chronic pressure overload compared with MK5 ϩ/ϩ littermates. After 8 wk of chronic pressure overload, lateral S m was significantly reduced in MK5 ϩ/ϩ and MK5 ϩ/Ϫ hearts. Septal S m was also reduced in MK5 ϩ/ϩ and MK5 ϩ/Ϫ hearts, but the change failed to reach significance. Furthermore, 8 wk post-TAC, IVRTs in TAC mice did not differ significantly from those in sham-operated mice (Fig. 4B) . Alternatively, the E wave deceleration rate, which was increased in TAC MK5 ϩ/ϩ mice at both 2 and 8 wk ( Fig. 4C and Table 4 ), was significantly lower in TAC MK5 ϩ/Ϫ than TAC MK5 ϩ/ϩ hearts 8 wk post-TAC (31.4 Ϯ 2.3 vs. 41.1 Ϯ 3.1 m/s 2 , P Ͻ 0.05). There were no significant differences in MPI 8 wk post-TAC (Fig. 4D ). Hence, in response to chronic pressure overload, both MK5 ϩ/ϩ and MK5 ϩ/Ϫ mice developed a reduced systolic function, whereas MK5 ϩ/ϩ mice showed a more restrictive cardiac filling pattern in response to TAC.
Fibrosis in MK5 ϩ/Ϫ hearts after TAC. In addition to LV hypertrophy and molecular remodeling, chronic pressure over-load induces interstitial fibrosis. Collagen type 1 accounts for 85% of the total collagen content of the heart. Consequently, COL1A1 mRNA levels were measured by quantitative PCR and found to increase as a result of pressure overload (Fig. 5A) . Two weeks post-TAC, the increase in COL1A1 mRNA was reduced by 50% in MK5 ϩ/Ϫ hearts compared with MK5 ϩ/ϩ hearts. Eight weeks post-TAC, although variable, COL1A1 mRNA levels in TAC hearts appeared to be returning to levels similar to those in sham mice. No significant difference was observed in COL1A1 mRNA levels between sham MK5 ϩ/ϩ and sham MK5 ϩ/Ϫ hearts. Hence, collagen accumulation was examined in cryosections of the ventricular myocardium by Masson's trichrome staining. Two (data not shown) and eight (Fig. 5, B and C) weeks of pressure overload resulted in negligible increases in collagen deposition in TAC MK5 ϩ/ϩ and TAC MK5 ϩ/Ϫ hearts. No genotype-dependent differences in collagen deposition were observed in sham hearts. After constriction of the transverse aorta, pressure in the right carotid artery was elevated ( Assessment of transforming growth factor-␤ expression in MK5 ϩ/Ϫ mice post-TAC. Members of the transforming growth factor (TGF)-␤ family are mediators of fibroblast activation, with TGF-␤ 1 serving a major role in pathological fibrosis (25, 55) . TGF-␤ 1 has also been shown to mediate cardiomyocyte hypertrophy (45) . Furthermore, hypertrophy induced by aortic banding or phenylephrine infusion is associated with increased TGF-␤ 1 mRNA (53, 56) , as is myocardial infarction (54), genetically determined hypertrophy (43) , and idiopathic hypertrophic cardiomyopathy (26) . To determine if the induction of TGF-␤ expression in response to pressure overload is altered in MK5 haplodeficient mice, we assessed TGF-␤ 1 and TGF-␤ 3 mRNA levels by quantitative PCR in total RNA from sham and TAC hearts (Fig. 6 ). TGF-␤ 1 and TGF-␤ 3 mRNA levels showed only modest increases in both MK5 ϩ/ϩ and MK5 ϩ/Ϫ hearts 2 wk post-TAC. By 8 wk postsurgery, the TAC-induced increase in TGF-␤ 3 mRNA had reached significance in MK5 ϩ/ϩ hearts (Fig. 6B ). However, in general, there was no correlation between changes in the abundance of COL1A1 mRNA and changes in TGF-␤ mRNA.
Expression of MK5 in heart cells. MK5 immunoreactivity was detected in lysates prepared from whole mouse heart (Fig.  1, A and B) . As the ability of a chronic pressure overload to both induce hypertrophy and increase COL1A1 mRNA levels was attenuated in hearts from MK5 ϩ/Ϫ mice, we sought to verify that MK5 is expressed in both ventricular myocytes and fibroblasts. Ventricular myocytes and fibroblasts were isolated from adult mouse hearts, lysates were prepared and resolved by SDS-PAGE, and the presence of MK5 immunoreactivity determined by immunoblot analysis. Surprisingly, MK5 immunoreactivity was detected in fibroblasts but not in myocytes (Fig. 7A ). We previously reported that 1 wk after surgery, the abundance of MK5 mRNA in TAC and sham mouse ventricular myocardium did not differ significantly (11) . Figure 7B shows that the abundance of MK5 immunoreactivity in hearts from either MK5 ϩ/ϩ or MK5 ϩ/Ϫ mice was not affected by 8 wk of TAC. As mentioned above, the line of mice used in this study have roughly a 50% reduction in MK5, and MK5 is able to bind several other signaling proteins, including p38, ERK3, and ERK4; hence, the phenotype may result from a reduction in activatable MK5 or a reduction in MK5 as a molecular scaffold. We attempted to determine if MK5 was activated during TAC using anti-MK5 phospho-Thr 182 , which reports on the phosphorylation status of MK5 at the activating Thr residue. Unfortunately, the antibody revealed numerous nonspecific bands in heart lysates from sham and TAC hearts (not shown).
To determine if reduced levels of MK5 impaired the phenoconversion of fibroblasts into myofibroblasts, ␣-smooth muscle actin expression was examined. When ventricular fibroblasts were isolated from MK5 ϩ/ϩ , MK5 ϩ/Ϫ , and MK5 Ϫ/Ϫ mice and maintained in culture for 6 days, no genotype-specific differences in the abundance of ␣-smooth muscle actin immunoreactivity were detected by immunoblot analysis (Fig. 7C) . Hence, the cardiac phenotype observed in MK5 haplodeficient mice reflects the role of this protein serine/threonine kinase in 
DISCUSSION
In vitro and in vivo studies have suggested the involvement of MK5 downstream of p38 MAPK (31-33, 48, 52) , although the biological role of MK5 remains unknown. We show here that 12-wk-old MK5 haploinsufficient mice were 6 -7% smaller than age-and sex-matched wild-type littermates and showed normal LV diastolic function but reduced systolic LV function (4.5% decrease in EF). In response to chronic pressure overload, hearts from MK5 ϩ/Ϫ mice reexpressed fetal genes (e.g., ANP, BNP, and ␤-MHC) and hypertrophied. However, the profile of fetal gene expression evoked by TAC differed from wild-type mice, and hearts from MK5 ϩ/Ϫ mice showed significantly less hypertrophy 8 wk post-TAC than hearts from MK5 ϩ/ϩ mice. Furthermore, the increase in COL1A1 mRNA induced by chronic pressure overload was attenuated in MK5 ϩ/Ϫ mice compared with MK5 ϩ/ϩ littermates. Finally, whereas MK5 ϩ/ϩ hearts developed a more restrictive filling pattern in response to TAC, MK5 ϩ/Ϫ hearts did not. These results suggest that MK5 could mediate the function of both ventricular fibroblasts and myocytes; however, MK5 immunoreactivity was detected in fibroblasts but not in myocytes, suggesting a role for MK5 in paracrine regulation of myocyte function by fibroblasts. MK5 may mediate at least some of the pathological remodeling associated with p38 activation in the heart; however, MK5 is also regulated by, and remains one of the few known physiological substrate for, the atypical MAPKs ERK3 and ERK4 (1, 21, 46, 49) . In the murine heart, MK5 associates with ERK3 but not ERK4 or p38␣ (11) .
Several signaling pathways are activated in cardiac tissues in response to pressure overload, including MAPK pathways, calcineurin-nuclear factor of activated T cells (NFAT), and the phosphatidylinositol 3-kinase (PI3K)/PKB pathway (18) . Seven distinct MAPK pathways have been identified in mammals: ERK1/2, ERK3/4, ERK5, ERK7, JNKs, p38 MAPKs (␣, ␤, ␦, and ␥), and Nemo-like kinase (NLK) (8) . Pressure overload activates p38␣ and p38␤ and causes the accumulation of p38␥ in the nucleus (12, 57) . Transfection of neonatal myocytes with activated mutants of MAPKK 6b (MKK6b) or MKK3b, upstream activators of p38␣ and p38␤, evokes changes characteristic of the hypertrophic phenotype and apoptosis, respectively (57) . In the intact heart, the situation is more complicated. Chronic inhibition of p38 signaling, using cardiac-directed expression of dominant negative (DN)-p38␣, DN-p38␤, DN-MKK3, or DN-MKK6, facilitates cardiac hypertrophy and expression of fetal genes (ANP and BNP) but not fibrosis in response to pressure overload (6, 60) or infusion of ANG II, isoproterenol, or phenylephrine (6) . In addition, cardiac-specific expression of constitutively active MKK3bE or MKK6bE results in cardiac fibrosis and both systolic and diastolic dysfunction but not hypertrophy (28) in some cases but hypertrophy in others (14) . Expression of an activated form of TGF-␤-activated kinase (TAK1) in heart results in p38 activation associated with hypertrophy (59) . Cardiac-specific p38␣ Ϫ/Ϫ mice exhibit hypertrophy in response to aortic banding but also show cardiac dysfunction and dilation accompanied by massive fibrosis and myocyte apoptosis (34) . One explanation for the differences observed using in vivo models is that the chronic nature of the modification in p38 signaling used in these models may interfere with other aspects of intracellular signaling or induce compensatory mechanisms. The role of p38 in hypertrophy may depend on the nature and/or duration of the hypertrophic stimulus (27, 34, 35) as the nature and intensity of the stimuli have been shown to alter which p38 isoforms become activated (37) . Consistent with this, acute activation of p38␣, induced by the conditional and **** myocyte-specific expression of MKK3bEE, in the adult mouse heart results in the rapid onset of a severe cardiomyopathy involving hypertrophy, interstitial fibrosis, and impaired cardiac function (51) . In addition, mice lacking the p38␣/␤ target MK2 do not develop diabetic cardiomyopathy in a murine model of type 2 diabetes (42) . Hence, inhibition of p38 would be a desirable pharmacological intervention in the treatment of cardiovascular disease. However, clinical trials of p38 inhibitors have revealed adverse effects, including hepatotoxicity, rash, and dizziness as well as loss of efficacy during chronic inhibition (30, 58) . In addition, as the means whereby p38 mediates deleterious effects upon cardiac structure and function remains largely unknown, a better understanding of the roles and regulation of downstream targets of p38, including MK2/3 and MK5, is an important step toward both understanding the role of p38 signaling in cardiomyopathies and the development of more selective therapies. Chronic pressure overload induces cardiac fibroblast proliferation, increased interstitial fibrosis, and remodeling of the extracellular matrix (10) . Cardiac interstitial fibrosis can result from either enhanced collagen deposition or reduced degradation. Collagen type I and type III are the major components of the cardiac extracellular matrix, with collagen type 1 compris-ing~85% of total collagen in the heart and hence representing a major determinant for myocardial stiffness (4, 17) . In MK5 ϩ/Ϫ hearts, there was a significant reduction in the ability of pressure overload to increase COL1A1 mRNA synthesis and/or stability. TGF-␤ is a cytokine expressed in both myocytes and fibroblasts, which acts upon receptors that are also expressed in both cell types. In ventricular myocytes, TGF-␤ induces molecular remodeling and hypertrophy (40) , whereas in fibroblasts, it induces proliferation, differentiation to myofibroblasts, and production of extracellular matrix proteins including collagen, fibronectin, and proteoglycans (39) . TGF-␤ also reduces extracellular matrix breakdown by both inhibiting matrix metalloproteinase expression and by inducing the synthesis of matrix metalloproteinase inhibitors, such as plasminogen activator inhibitor-1 and tissue inhibitors of metalloproteinases (44) . In rats, aortic banding evokes an increase in myocardial TGF-␤ mRNA (7, 53, 56) within 12 h of aortic banding that has decreased to near control levels within 2 wk (56) . In the present study, where TGF-␤ mRNA was assessed after 2 and 8 wk of chronic pressure overload, no persistent increase in TGF-␤ 1 mRNA was detected in TAC MK5 ϩ/Ϫ mice. Furthermore, the increase in TGF-␤ 1 mRNA observed in rats after aortic banding occurred in cardiomyocytes but not in nonmyocytes (7, 53) , whereas we detected MK5 immunoreactivity in fibroblasts but not in myocytes, suggesting a role for MK5 in fibroblast function. The only significant difference in TGF-␤ mRNA levels observed in the present study was an increase in TGF-␤ 3 mRNA in MK5 ϩ/ϩ but not MK5 ϩ/Ϫ hearts 8 wk post-TAC. Very little is currently known regarding the role of TGF-␤ 3 in cardiac remodeling; however, a TGF-␤ 3 polymorphism has been associated with changes in LV geometry in hypertensive patients (19) . ␤-Adrenergic receptor signaling has been implicated downstream of TGF-␤ 1 , and the catalytic subunit of PKA has been recently shown to phosphorylate MK5, resulting in its activation and translocation out of the nucleus (15, 22) . However, as ␤ 1 -adrenergic receptor blockade in mice overexpressing TGF-␤ 1 is antihypertrophic but not antifibrotic (47) , whereas MK5 haploinsufficiency attenuated the TAC-induced increase in COL1A1 mRNA, it is unlikely that MK5 haploinsufficiency is preventing fibrosis by attenuating TGF-␤ 1 /␤-adrenergic receptor signaling in the heart. Further study will be required to determine the exact role(s) that MK5 plays in the fibrotic response induced by chronic pressure overload.
Potential limitations. Although the line of mice used in this study hypertrophied in response to TAC and COL1A1 mRNA was increased, they showed very little fibrosis. This may have been a characteristic of their being on a mixed 129/Ola ϫ C57BL background. Attempts to backcross onto a C57BL/6 background were not successful (Sylvain Meloche, Université de Montréal, personal communication). The genetic modifica- H55 ROLE OF MK5 IN CARDIAC REMODELING tion used to generate these mice reduced the total amount of MK5 protein, not just the amount of activatable MK5. As MK5 has been shown to form complexes with several signaling proteins, including p38 MAPK (32, 48) , ERK3 (11, 46) , ERK4 (1, 21) , Cdc14A (16), kalirin-7 (5), and septins 7 and 8 (5), it is not clear at present if the cardiac phenotype we observed was a result of reduced MK5 activity per se or alterations in protein-protein interactions resulting from a reduction in MK5 as a molecular scaffold. Differences in systolic function in the form of reduced LV EF and LV FS observed in MK5 haplodeficient mice at 12 wk of age were not observed in the sham mice postsurgery but were observed in both TAC MK5 ϩ/ϩ and TAC MK5 ϩ/Ϫ mice, which showed reduced systolic function compared with their respective sham groups. As the sham groups had undergone major surgery, verification of these observations would require further study in the form of a longitudinal study to determine if this was an effect of aging versus surgery upon systolic function in the sham groups.
Conclusions. Here, we showed that MK5 ϩ/Ϫ mice have reduced EF at 12 wk of age. Although MK5 ϩ/Ϫ hearts hypertrophied in response to chronic pressure overload, the progression of hypertrophic growth was significantly attenuated 8 wk post-TAC. Two weeks post-TAC, the increase in COL1A1 mRNA level was significantly lower in TAC MK5 ϩ/Ϫ hearts compared with TAC MK5 ϩ/ϩ hearts. TAC MK5 ϩ/Ϫ hearts did not develop the restrictive filling pattern observed in TAC MK5 ϩ/ϩ hearts. In contrast, systolic function was similarly reduced in both TAC MK5 ϩ/ϩ and TAC MK5 ϩ/Ϫ mice. That MK5 immunoreactivity was only detected in cardiac fibroblasts suggests that MK5 plays a role in the cardiac fibroblast response to chronic pressure overload and the reduced hypertrophy was a consequence of alterations in paracrine signaling or direct fibroblast-myocyte coupling. Our findings reveal a novel role for MK5 during the pathological cardiac remodeling induced by chronic pressure overload and suggest that it may mediate some of the pathological effects of p38 activation. However, the atypical MAPKs ERK3 and ERK4 also activate MK5, and the role of these kinases in cardiac pathophysiology remains to be determined. 
